Tough times: how regulatory affairs professionals can deal with sudden career change
This article was originally published in SRA
The wave of redundancies in the pharmaceutical and medical device industries is hitting regulatory affairs professionals as well as their colleagues in other departments. Zubair Hussain offers some careers advice.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.